WO2013189694A3 - Verwendung von parfümrohstoffen zur behandlung der altershaut - Google Patents

Verwendung von parfümrohstoffen zur behandlung der altershaut Download PDF

Info

Publication number
WO2013189694A3
WO2013189694A3 PCT/EP2013/060840 EP2013060840W WO2013189694A3 WO 2013189694 A3 WO2013189694 A3 WO 2013189694A3 EP 2013060840 W EP2013060840 W EP 2013060840W WO 2013189694 A3 WO2013189694 A3 WO 2013189694A3
Authority
WO
WIPO (PCT)
Prior art keywords
cas
raw materials
ageing skin
perfume raw
supra
Prior art date
Application number
PCT/EP2013/060840
Other languages
English (en)
French (fr)
Other versions
WO2013189694A2 (de
Inventor
Julia WEISE
Stefanie TANG
Heiko Mielke
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Priority to EP13725161.7A priority Critical patent/EP2863878A2/de
Publication of WO2013189694A2 publication Critical patent/WO2013189694A2/de
Publication of WO2013189694A3 publication Critical patent/WO2013189694A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Fats And Perfumes (AREA)

Abstract

Verwendung von einem oder mehreren Parfümrohstoff(en), gewählt aus der Gruppe: Cumarin (CAS-Nr.: 91-64-5), Iraldein alpha iff (CAS-Nr.: 127-41-3), Farnesol (CAS-Nr.: 4602-84-0), Lilial (CAS-Nr.: 80-54-6), Orangenöl bitter (CAS-Nr.: 8028-48-6), Florosa (CAS-Nr.: 63500-71-0), Hexylsalicylat (CAS-Nr.: 6259-76-3), Phenylethylalkohol (CAS-Nr.: 60-12-8), Benzylbenzoat M (CAS-Nr.: 120-51-4), Hydroxycitronellal (CAS-Nr.: 107- 75-5), Macrolide Supra (CAS-Nr.: 106-02-5), Phenoxanol (CAS-Nr.: 55066-48-3), Geraniol Supra (CAS-Nr.: 106-24-1 ), Dihydromyrcenol (CAS-Nr.: 18479-58-8), Zimtaldehyd (CAS-Nr.: 104-55-2), Lyral (CAS-Nr.: 31906-04-4), Isoeugenol (CAS-Nr.: 97- 54-1 ), Anisalkohol (CAS-Nr.: 105-13-5), Terpineol rein (CAS-Nr.: 98-55-5), Bergamotteöl (CAS-Nr.: 8007-75-8), Hedion (CAS-Nr.: 24851 -98-7), Vanillin (CAS-Nr.: 121-33-5), Thymol (CAS-Nr.: 89-83-8) zur Stimulierung der Expression von Endo180 zur Aktivierung des Kollagen-Stoffwechsels in der Altershaut und zur Anregung der Altershaut, defektes Kollagen zu beseitigen.
PCT/EP2013/060840 2012-06-20 2013-05-27 Kosmetische und dermatologische zubereitung enthaltend eine oder mehrere substanz(en), die das gen / protein für den rezeptor endo180 modulieren WO2013189694A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP13725161.7A EP2863878A2 (de) 2012-06-20 2013-05-27 Kosmetische und dermatologische zubereitung enthaltend eine oder mehrere substanz(en), die das gen / protein für den rezeptor endo180 modulieren

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012210399A DE102012210399A1 (de) 2012-06-20 2012-06-20 Kosmetische und dermatologische Zubereitung enthaltend eine oder mehrere Substanz(en), die das Gen / Protein für den Rezeptor Endo180 modulieren
DE102012210399.6 2012-06-20

Publications (2)

Publication Number Publication Date
WO2013189694A2 WO2013189694A2 (de) 2013-12-27
WO2013189694A3 true WO2013189694A3 (de) 2014-06-26

Family

ID=48520968

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/060840 WO2013189694A2 (de) 2012-06-20 2013-05-27 Kosmetische und dermatologische zubereitung enthaltend eine oder mehrere substanz(en), die das gen / protein für den rezeptor endo180 modulieren

Country Status (3)

Country Link
EP (1) EP2863878A2 (de)
DE (1) DE102012210399A1 (de)
WO (1) WO2013189694A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7455344B2 (ja) 2018-04-03 2024-03-26 丸善製薬株式会社 Ｅｎｄｏ１８０産生促進剤

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6781549B2 (ja) * 2016-01-21 2020-11-04 丸善製薬株式会社 Ｅｎｄｏ１８０産生促進剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030180231A1 (en) * 2000-08-29 2003-09-25 Louis Danoux Use of extracts of the cassia alata plant
FR2877219A1 (fr) * 2004-10-28 2006-05-05 Fatima Basri Composition utilisee en cosmetique ou en pharmacologie pour stimuler la synthese du collagene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063390A (en) * 1998-08-07 2000-05-16 Chesebrough-Pond's Usa Co., A Division Of Conopco, Inc. Cosmetic effervescent cleansing pillow
DE102005056393A1 (de) * 2005-11-24 2007-05-31 Grünenthal GmbH Multicyclische Verbindungen in druckempfindlichen Klebstoffen
DE102008034944B4 (de) * 2008-07-26 2017-03-16 Arivine Pharma Ag Mikroemulsion

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030180231A1 (en) * 2000-08-29 2003-09-25 Louis Danoux Use of extracts of the cassia alata plant
FR2877219A1 (fr) * 2004-10-28 2006-05-05 Fatima Basri Composition utilisee en cosmetique ou en pharmacologie pour stimuler la synthese du collagene

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7455344B2 (ja) 2018-04-03 2024-03-26 丸善製薬株式会社 Ｅｎｄｏ１８０産生促進剤

Also Published As

Publication number Publication date
DE102012210399A1 (de) 2013-12-24
WO2013189694A2 (de) 2013-12-27
EP2863878A2 (de) 2015-04-29

Similar Documents

Publication Publication Date Title
EP3854376A3 (de) Systeme für individuelle färbung
ECSP12012097A (es) Derivados de fumarato de ácido graso y sus usos
CO6420355A2 (es) Anticuerpos biespecíficos anti-erbb-3/anti-c-met
ECSP13011139A (es) Anticuerpos contra la angiopoyetina 2 humana
BRPI0905733B8 (pt) composição, formulação farmacêutica, método para a produção de uma composição farmacêutica e uso de uma formulação farmacêutica
MX2019009621A (es) Composiciones antitranspirantes y desodorantes.
BR112018069876A2 (pt) composição cosmética, método para fotoestabilização de resveratrol, polidatina, ou uma mistura dos mesmos com baicalina e método
CO7081144A2 (es) Anticuerpos biespecíficos contra tweak humana e il17 humana y usos de los mismos
AR090360A1 (es) Esteviol glucosiltransferasas y genes que las codifican
BR112018012694A2 (pt) composição de célula dendrítica, vacina de célula dendrítica, composição e kit
CR20110639A (es) Mutantes fgf21 y usos de los mismos
BR112013013919B8 (pt) método para remodelação permanente e, em particular, para alisamento, que compreende uma etapa de alisamento de fibras de queratina utilizando uma composição compreendendo pelo menos 40% em peso de substâncias graxas que não são de silicone
BR112016021345A8 (pt) Composições de vacina de molécula de ácido nucleico e usos das mesmas
BR112017019358A2 (pt) combinações e formulações de dose fixa compreendendo etc1002 e ezetimiba e métodos de tratamento ou redução do risco de doença cardiovascular
PH12019502469A1 (en) Novel fragrance compositions and products with mood enhancing effects
BR112017021191A2 (pt) um extrato de indigo naturalis e um processo para preparar o mesmo
PH12017502404A1 (en) Musk compositions and methods of use thereof
WO2014090526A3 (de) Wirkstoffkombination zur hautaufhellung i
UY33208A (es) Composiciones que comprenden productos de azúcar cisteína
WO2013189694A3 (de) Verwendung von parfümrohstoffen zur behandlung der altershaut
EA201491426A1 (ru) Новые фармацевтические композиции, содержащие фосфатидилсерин и куркумин
BR112012005239A2 (pt) compostos odoríferos, seus usos como odorantes, composição de fragrância compreendendo os mesmos, método de criação, intensificação ou modificação de composição de fragrância, e método para aprimorar, intensificar ou modificar produto de fragrância
PH12016501266A1 (en) Solubilisation of uv filters
BR112016030728A2 (pt) método para tratar ou prevenir uma inflamação induzida por bactérias em um indivíduo, composição imunogênica, composição farmacêutica, uso da composição imunogênica, método para produzir uma composição imunogênica, e, método para tratar ou prevenir uma doença
WO2014090524A3 (de) Wirkstoffe zur hautaufhellung ii

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2013725161

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13725161

Country of ref document: EP

Kind code of ref document: A2